View in EDS

665P Safety, PK, immune activation, and clinical outcomes with RBS2418 treatment, an oral ENPP1 inhibitor, alone or in combination with pembrolizumab in advanced solid tumors.

Saved in:
Bibliographic Details
Title: 665P Safety, PK, immune activation, and clinical outcomes with RBS2418 treatment, an oral ENPP1 inhibitor, alone or in combination with pembrolizumab in advanced solid tumors.
Authors: Marron, T.1 (AUTHOR), Segar, J.2 (AUTHOR), Berlin, J.D.3 (AUTHOR), Boccia, R.4 (AUTHOR), Spira, A.I.5 (AUTHOR), Powderly, J.6 (AUTHOR), Chen, C.7 (AUTHOR), Wainberg, Z.A.8 (AUTHOR), Schanzer, J.M.9 (AUTHOR), Glenn, J.10 (AUTHOR), Klumpp, K.11 (AUTHOR), Csiki, I.12 (AUTHOR), Misleh, J.G.13 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS523-S523. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179692129
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 665P Safety, PK, immune activation, and clinical outcomes with RBS2418 treatment, an oral ENPP1 inhibitor, alone or in combination with pembrolizumab in advanced solid tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Marron%2C+T%2E%22">Marron, T.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Segar%2C+J%2E%22">Segar, J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berlin%2C+J%2ED%2E%22">Berlin, J.D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boccia%2C+R%2E%22">Boccia, R.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Spira%2C+A%2EI%2E%22">Spira, A.I.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Powderly%2C+J%2E%22">Powderly, J.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+C%2E%22">Chen, C.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wainberg%2C+Z%2EA%2E%22">Wainberg, Z.A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schanzer%2C+J%2EM%2E%22">Schanzer, J.M.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Glenn%2C+J%2E%22">Glenn, J.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Klumpp%2C+K%2E%22">Klumpp, K.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Csiki%2C+I%2E%22">Csiki, I.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Misleh%2C+J%2EG%2E%22">Misleh, J.G.</searchLink><relatesTo>13</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS523-S523. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179692129
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2024.08.731
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S523
    Titles:
      – TitleFull: 665P Safety, PK, immune activation, and clinical outcomes with RBS2418 treatment, an oral ENPP1 inhibitor, alone or in combination with pembrolizumab in advanced solid tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Marron, T.
      – PersonEntity:
          Name:
            NameFull: Segar, J.
      – PersonEntity:
          Name:
            NameFull: Berlin, J.D.
      – PersonEntity:
          Name:
            NameFull: Boccia, R.
      – PersonEntity:
          Name:
            NameFull: Spira, A.I.
      – PersonEntity:
          Name:
            NameFull: Powderly, J.
      – PersonEntity:
          Name:
            NameFull: Chen, C.
      – PersonEntity:
          Name:
            NameFull: Wainberg, Z.A.
      – PersonEntity:
          Name:
            NameFull: Schanzer, J.M.
      – PersonEntity:
          Name:
            NameFull: Glenn, J.
      – PersonEntity:
          Name:
            NameFull: Klumpp, K.
      – PersonEntity:
          Name:
            NameFull: Csiki, I.
      – PersonEntity:
          Name:
            NameFull: Misleh, J.G.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2024 Supplement 2
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 35
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1